PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges.

PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges.

Item
http://www.wikidata.org/entity/Q38838649
Immune-Mediated Therapies for Liver Cancer.Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors.PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma.Part I: Checkpoint inhibitors in cancer therapy.DNA methylation/hydroxymethylation in melanoma.Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature.Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice.The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease.
P2860

PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges.

Item
http://www.wikidata.org/entity/Q38838649
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PD-1 and PD-L1 inhibitors in m ...... ication and future challenges.
@en
type
label
PD-1 and PD-L1 inhibitors in m ...... ication and future challenges.
@en
prefLabel
PD-1 and PD-L1 inhibitors in m ...... ication and future challenges.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
PD-1 and PD-L1 inhibitors in m ...... lication and future challenges
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698